Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FTGLA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,083
Award facts
- Contract value 100% obligated
- $21,082.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,082.77 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen 2 ml on May 6, 2025, with an ultimate completion date of May 7, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The place of performance is located in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems through the DLA Medical Supply Chain. Cosentyx, a specialty immunosuppressant medication used in the treatment of autoimmune conditions, falls within the company's extensive portfolio of brand-name and generic medications delivered under its prime vendor agreement. This delivery order exemplifies the routine pharmaceutical procurement activities supported through AmerisourceBergen's flexible global pharmaceutical support vehicle, which serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FTGLA?
SPE2DB25FTGLA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 6, 2025.
How much is contract SPE2DB25FTGLA worth?
The government has obligated $21,083 on SPE2DB25FTGLA.
Is contract SPE2DB25FTGLA an order under another contract?
Yes. SPE2DB25FTGLA is a delivery order under SPE2DB25D2204, an indefinite delivery contract.
Was contract SPE2DB25FTGLA competed?
The extent of competition for SPE2DB25FTGLA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award